Major trial tests new COVID-19 vaccine in vietnam
NCT ID NCT05012943
First seen Nov 06, 2025 · Last updated Apr 16, 2026 · Updated 22 times
Summary
This study tested a new COVID-19 vaccine called ARCT-154 to see if it is safe and effective at preventing COVID-19. It involved over 19,000 adults in Vietnam, including older people and those with other health conditions. The vaccine was compared to a placebo (a dummy shot) and to another approved COVID-19 vaccine to measure its ability to trigger an immune response and prevent illness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 VACCINES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Hanoi Medical University
Hanoi, Hanoi, 00000, Vietnam
-
Military Medical University
Hanoi, Hanoi, 00000, Vietnam
-
Pasteur Institute
Ho Chi Minh City, Ho Chi Minh, 00000, Vietnam
Conditions
Explore the condition pages connected to this study.